Evidence map›Paper›PMID 32918819›Full record

ArticleEuropean journal of public health2020

Awareness and correlates of noticing changes to cigarette packaging design after implementation of the European Tobacco Products Directive: findings from the EUREST-PLUS ITC Europe Surveys.

Christina N Kyriakos, Pete Driezen, Charis Girvalaki, Sara C Hitchman, Filippos T Filippidis, Shannon Gravely, James Balmford, Katerina Nikitara, Ute Mons, Esteve Fernández and 8 more

Abstract read
In one paragraph

Article in European journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Health Claims, Marketing Appeals, and Warnings on Popular Brands of Waterpipe Tobacco Packaging Sold in the United States.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Christina N KyriakosLaboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
Pete DriezenDepartment of Psychology, University of Waterloo, Waterloo, Canada.
Charis GirvalakiLaboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
Sara C HitchmanAddictions Department, King's College London, London, UK.
Filippos T FilippidisDepartment of Primary Care and Public Health, Imperial College London, London, UK.
Shannon GravelyDepartment of Psychology, University of Waterloo, Waterloo, Canada.
James BalmfordInstitute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.
Katerina NikitaraEuropean Network for Smoking and Tobacco Prevention, Brussels, Belgium.
Ute MonsCancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Esteve FernándezTobacco Control Unit, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat (Barcelona), Catalonia, Spain.
Krzysztof PrzewoźniakHealth Promotion Foundation, Warsaw, Poland.
Antigona C TroforUniversity of Medicine and Pharmacy 'Grigore T. Popa' Iasi, Iasi, Romania.
Tibor DemjénSmoking or Health Hungarian Foundation, Budapest, Hungary.
Witold ZatońskiHealth Promotion Foundation, Warsaw, Poland.
Yannis TountasCenter for Health Services Research, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Geoffrey T FongLaboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
Constantine I VardavasLaboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
EUREST-PLUS Consortium

Funding

CIHR FDN-148477
6 · The paper itself

Abstract

backgroundThe European Tobacco Products Directive (TPD), which went into effect in May 2016, regulates packaging design and labelling of cigarettes and roll-your-own (RYO) tobacco. The aim of the current study was to examine whether smokers and recent quitters in six European Union (EU) countries (Germany, Greece, Hungary, Poland, Romania and Spain) reported noticing TPD-related changes to packaging, and correlates of noticing these changes.

methodsCross-sectional data from the Wave 2 of the ITC 6 European Country Survey in 2018 after implementation of the TPD. Bivariate analyses included adult smokers (n = 5597) and recent quitters (n = 412). Adjusted logistic regression analyses were restricted to the subset of current smokers (n = 5597) and conducted using SAS-callable SUDAAN.

resultsOver half of smokers (58.2%) and 30% of quitters noticed at least one of five types of TPD-related pack changes. Over one-quarter of all respondents noticed changes to health warnings (30.0%), standardized openings (27.7%), minimum pack unit size (27.9%), and the removal of tar, nicotine and carbon monoxide information (26.7%) on packaging. Cross-country differences were observed across all measures, with noticing all pack changes markedly lower in Spain than the other countries. Correlates of noticing specific pack changes included sociodemographic characteristics, smoking behaviours and related to packaging.

conclusionsThis is one of the first cross-country studies to examine the extent to which TPD changes to cigarette and RYO tobacco packaging are being noticed by smokers and recent quitters. Findings indicate that the majority of smokers noticed at least one type of pack change, but this varied across countries and sub-populations.

Indexed as

Product LabelingTobacco ProductsAdolescentAdultCohort StudiesCross-Sectional StudiesEuropeFemaleGermanyGreeceHumansHungaryMaleMiddle AgedPolandProduct Packaging

Identifiers

PMID32918819
PMCPMC7526785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.